Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis

Atherosclerosis and atherothrombosis, the major contributors to cardiovascular diseases (CVDs), represent the leading cause of death worldwide. Current pharmacological therapies have been associated with side effects or are insufficient at halting atherosclerotic progression effectively. Pioneering...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haikun, Pietersz, Geoffrey, Peter, Karlheinz, Wang, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822797/
https://www.ncbi.nlm.nih.gov/pubmed/35135581
http://dx.doi.org/10.1186/s12951-022-01279-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822797/
https://www.ncbi.nlm.nih.gov/pubmed/35135581
http://dx.doi.org/10.1186/s12951-022-01279-y

Ejemplares similares